<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101581613</journal-id>
<journal-id journal-id-type="pubmed-jr-id">40077</journal-id>
<journal-id journal-id-type="nlm-ta">Adv Healthc Mater</journal-id>
<journal-id journal-id-type="iso-abbrev">Adv Healthc Mater</journal-id>
<journal-title-group>
<journal-title>Advanced healthcare materials</journal-title>
</journal-title-group>
<issn pub-type="ppub">2192-2640</issn>
<issn pub-type="epub">2192-2659</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28845922</article-id>
<article-id pub-id-type="pmc">5762251</article-id>
<article-id pub-id-type="doi">10.1002/adhm.201700723</article-id>
<article-id pub-id-type="manuscript">NIHMS902479</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Three-Dimensional Models of the Human Brain Development and Diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jorfi</surname>
<given-names>Mehdi</given-names>
<prefix>Dr.</prefix>
</name>
<aff id="A1">Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA</aff>
<!--<email>mjorfi@mgh.harvard.edu</email>-->
</contrib>
<contrib contrib-type="author">
<name>
<surname>D’Avanzo</surname>
<given-names>Carla</given-names>
<prefix>Dr.</prefix>
</name>
<aff id="A2">Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kim</surname>
<given-names>Doo Yeon</given-names>
<prefix>Prof.</prefix>
</name>
<aff id="A3">Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA</aff>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Irimia</surname>
<given-names>Daniel</given-names>
<prefix>Prof.</prefix>
</name>
<aff id="A4">Center for Engineering in Medicine, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA</aff>
<!--<email>dirimia@mgh.harvard.edu</email>-->
</contrib>
</contrib-group>
<author-notes>
<fn id="FN1">
<p>The ORCID identification number(s) for the author(s) of this article can be found under <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/adhm.201700723">https://doi.org/10.1002/adhm.201700723</ext-link>.</p>
</fn>
<fn fn-type="COI-statement" id="FN2">
<p>
<bold>Conflict of Interest</bold>
</p>
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>30</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>28</day>
<month>8</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>10</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>7</volume>
<issue>1</issue>
<elocation-id>10.1002/adhm.201700723</elocation-id>
<abstract>
<p id="P1">Deciphering the human brain pathophysiology remains one of the greatest challenges of the 21<sup>st</sup> century. Neurological disorders represent a significant proportion of diseases burden; however, the complexity of the brain physiology makes it challenging to model its diseases. Simple in vitro models have been very useful for precise measurements in controled conditions. However, existing models are limited in their ability to replicate complex interactions between various cells in the brain. Studying human brain requires sophisticated models to reconstitute the tangled architecture and functions of brain cells. Recently, advances in the development of three-dimensional (3D) brain cell culture models have begun to recapitulate various aspects of the human brain physiology in vitro and replicate basic disease processes of Alzheimer’s disease, amyotrophic lateral sclerosis, and microcephaly. In this review, we discuss the progress, advantages, limitations, and future directions of 3D cell culture systems for modeling the human brain development and diseases.</p>
</abstract>
<kwd-group>
<kwd>3D culture</kwd>
<kwd>biomaterials</kwd>
<kwd>disease modeling</kwd>
<kwd>microfluidics</kwd>
<kwd>organoids</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>